TACARYL Drug Patent Profile
✉ Email this page to a colleague
When do Tacaryl patents expire, and when can generic versions of Tacaryl launch?
Tacaryl is a drug marketed by Westwood Squibb and is included in one NDA.
The generic ingredient in TACARYL is methdilazine. There are four drug master file entries for this compound. Additional details are available on the methdilazine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TACARYL?
- What are the global sales for TACARYL?
- What is Average Wholesale Price for TACARYL?
Summary for TACARYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Patent Applications: | 2,588 |
| DailyMed Link: | TACARYL at DailyMed |
US Patents and Regulatory Information for TACARYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | TACARYL | methdilazine hydrochloride | SYRUP;ORAL | 011950-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Westwood Squibb | TACARYL | methdilazine | TABLET, CHEWABLE;ORAL | 011950-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Westwood Squibb | TACARYL | methdilazine hydrochloride | TABLET;ORAL | 011950-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
